Skip to main content


Table 1 Clinicopathological information.

From: Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses

Tumor Tumor ID Dukes' stage a TP53 mutation status b Sex c Age d
primary carcinomas 923P C wildtype M 85
  974P B ex8, c273, CGT→CAT, Arg→His M 73
  980P C wildtype F 75
  984P C wildtype F 88
  988P B wildtype F 66
  1029P C wildtype M 83
  1069P B wildtype M 74
  887P B wildtype F 82
  927P B ex6, c190, CCT→CTT, Pro→Leu F 73
  953P B ex6, 5 bp insertion; c216–217: GTG GTG to GTGgtggtGTG M 68
  976P B wildtype M 58
  1027P B ex7, c241–242, TCCTGC→TTCCGC, Ser-Cys→Phe-Arg M 79
  868P B wildtype M 64
  904P B ex8, c272, CTG→ATG, Val→Met M 78
  912P B wildtype F 66
  941P B ex8, c282, CGG→TGG, Arg→Trp M 78
  1276P B wildtype M 79
  1296P B ex7, c244, GGC→GTC, Gly→Val M 76
liver metastases 136L D ex5, c132, AAG→AGG, Lys→Arg M 68
  81L D wildtype M 74
  2L C wildtype M 75
  76L D ex7, c241, TCC→TC, 1 bp deletion M 55
carcinomatoses 98C D wildtype M 72
  1C D wildtype F 62
  17C C ex5, c175, CGC→CAC, Arg→His F 67
  64C D wildtype M 40
  1. aDukes' stage of the primary tumors, and the primary tumor of liver metastases and carcinomatoses. bex, exon; c, codon; bp, base pair. cM, male; F, female. dAge at diagnosis.